Scleral spacing procedure study to begin

February 15, 2004

The FDA has approved Refocus Group's request to begin phase II clinical trials of its scleral implants and scleral spacing procedure for the surgical treatment of presbyopia.

Related Content:

News | Surgery | Pharmacy